- Home
- AAPG vs NSIT Comparison
AAPG vs NSIT Comparison
Compare AAPG & NSIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AAPG | NSIT |
|---|---|---|
| Founded | 2009 | 1988 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.6B |
| IPO Year | 2025 | 1995 |
Fundamental Metrics
Financial Performance| Metric | AAPG | NSIT |
|---|---|---|
| Price | $32.88 | $86.06 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 3 |
| Target Price | $48.50 | ★ $128.33 |
| AVG Volume (30 Days) | 5.1K | ★ 439.4K |
| Earning Date | 11-19-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.21 |
| Revenue | $54,524,554.00 | ★ $8,271,548,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $368.64 | $2.57 |
| P/E Ratio | ★ N/A | $20.43 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $16.50 | $81.59 |
| 52 Week High | $48.45 | $181.92 |
Technical Indicators
Market Signals| Indicator | AAPG | NSIT |
|---|---|---|
| Relative Strength Index (RSI) | 50.39 | 34.42 |
| Support Level | $30.00 | $85.10 |
| Resistance Level | $33.09 | $90.38 |
| Average True Range (ATR) | 0.83 | 2.81 |
| MACD | 0.14 | 0.91 |
| Stochastic Oscillator | 72.07 | 42.78 |
Price Performance
Historical ComparisonAbout AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.
About NSIT Insight Enterprises Inc.
Insight Enterprises Inc is a Fortune IT provider engaged in helping businesses of all sizes, large enterprises, governments, schools, and healthcare organizations. The company has three geographic operating segments: North America, EMEA, and APAC. It generates maximum revenue from the North America segment. The company provides digital innovation, cloud/data center transformation, connected workforce, and supply chain optimization solutions and services.